Literature DB >> 2858687

Productive HTLV-III infection of human B cell lines.

M Tersmette, F Miedema, H G Huisman, J Goudsmit, C J Melief.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 2858687     DOI： 10.1016/s0140-6736(85)91469-2

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  9 in total

1.  Epstein-Barr virus-positive and -negative B-cell lines can be infected with human immunodeficiency virus types 1 and 2.

Authors:  J E Monroe; A Calender; C Mulder
Journal:  J Virol       Date:  1988-09       Impact factor: 5.103

2.  Biological significance of the antibody response to HIV antigens expressed on the cell surface.

Authors:  J Goudsmit; K Ljunggren; L Smit; M Jondal; E M Fenyö; M Jonda
Journal:  Arch Virol       Date:  1988       Impact factor: 2.574

3.  Differential syncytium-inducing capacity of human immunodeficiency virus isolates: frequent detection of syncytium-inducing isolates in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex.

Authors:  M Tersmette; R E de Goede; B J Al; I N Winkel; R A Gruters; H T Cuypers; H G Huisman; F Miedema
Journal:  J Virol       Date:  1988-06       Impact factor: 5.103

4.  Serum IgD elevation is an early marker of B cell activation during infection with the human immunodeficiency viruses.

Authors:  H Mizuma; S Zolla-Pazner; S Litwin; W el-Sadr; S Sharpe; B Zehr; S Weiss; W C Saxinger; M Marmor
Journal:  Clin Exp Immunol       Date:  1987-04       Impact factor: 4.330

5.  IgM, IgG and IgA rheumatoid factors and circulating immune complexes in patients with AIDS and AIDS-related complex with serological abnormalities.

Authors:  S Procaccia; A Lazzarin; A Colucci; A Gasparini; P Forcellini; D Lanzanova; C U Foppa; R Novati; C Zanussi
Journal:  Clin Exp Immunol       Date:  1987-02       Impact factor: 4.330

6.  Immunological abnormalities in human immunodeficiency virus (HIV)-infected asymptomatic homosexual men. HIV affects the immune system before CD4+ T helper cell depletion occurs.

Authors:  F Miedema; A J Petit; F G Terpstra; J K Schattenkerk; F de Wolf; B J Al; M Roos; J M Lange; S A Danner; J Goudsmit
Journal:  J Clin Invest       Date:  1988-12       Impact factor: 14.808

Review 7.  Principles of laboratory isolation and identification of the human immunodeficiency virus (HIV).

Authors:  B P Griffith
Journal:  Yale J Biol Med       Date:  1987 Nov-Dec

8.  MRN-100, an Iron-based Compound, Possesses Anti-HIV Activity In Vitro.

Authors:  Mamdooh Ghoneum; Magda Shaheen
Journal:  Evid Based Complement Alternat Med       Date:  2008-03-20       Impact factor: 2.629

9.  Phenotypic variation in the response to the human immunodeficiency virus among derivatives of the CEM T and WIL-2 B cell lines.

Authors:  S Chaffee; J M Leeds; T J Matthews; K J Weinhold; M Skinner; D P Bolognesi; M S Hershfield
Journal:  J Exp Med       Date:  1988-08-01       Impact factor: 14.307
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.